Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Bayona

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Lancet (London, England)|February 14, 2004
Programmes and principles in treatment of multidrug-resistant tuberculosisJoia S Mukherjee, Michael L Rich, Adrienne R Socci, et al.
Emerging Infectious Diseases|May 20, 2015
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countriesEkaterina V Kurbatova, Tracy Dalton, Julia Ershova, et al.
Emerging Infectious Diseases|November 1, 2006
Multidrug-resistant tuberculosis management in resource-limited settingsEva Nathanson, Catharina Lambregts-van Weezenbeek, Michael L Rich, et al.
Plos Medicine|December 30, 2015
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyCourtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, et al.
The Lancet. Infectious Diseases|May 14, 2017
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling studyAditya Sharma, Andrew Hill, Ekaterina Kurbatova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2014
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosisJ Peter Cegielski, Tracy Dalton, Martin Yagui, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Lancet (London, England)|February 14, 2004
Programmes and principles in treatment of multidrug-resistant tuberculosisJoia S Mukherjee, Michael L Rich, Adrienne R Socci, et al.
Emerging Infectious Diseases|May 20, 2015
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countriesEkaterina V Kurbatova, Tracy Dalton, Julia Ershova, et al.
Emerging Infectious Diseases|November 1, 2006
Multidrug-resistant tuberculosis management in resource-limited settingsEva Nathanson, Catharina Lambregts-van Weezenbeek, Michael L Rich, et al.
Plos Medicine|December 30, 2015
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyCourtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, et al.
The Lancet. Infectious Diseases|May 14, 2017
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling studyAditya Sharma, Andrew Hill, Ekaterina Kurbatova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2014
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosisJ Peter Cegielski, Tracy Dalton, Martin Yagui, et al.
The European Respiratory Journal|September 3, 2016
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological methodCarole D Mitnick, Richard A White, Chunling Lu, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Pageof 6